ArticleActa pharmacologica Sinica2024

SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs.

Wen-Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.